Table 2 Clinical symptom complexes
Overall cohort n (yes/no), (%) | rpAD n (yes/no), (%) | Non-rpAD n (yes/no), (%) | P-value (after MLRA) | |
|---|---|---|---|---|
Behavioral and psychiatric symptoms | ||||
Affective symptoms | 142/69 (67%) | 47/15 (76%) | 96/54 (64%) | 0.109 (0.200) |
Psychotic symptoms | 21/194 (10%) | 7/53 (12%) | 14/141 (9%) | 0.610 (0.381) |
Sleep disturbances | 57/157 (27%) | 20/41 (33%) | 37/116 (24%) | 0.231 (0.323) |
Focal neurological signs | ||||
Pyramidal signs | 5/199 (2%) | 4/57 (7%) | 1/141 (1%) | 0.029 (0.083) |
Extrapyramidal signs | 53/160 (25%) | 20/41 (33%) | 33/119 (22%) | 0.114 (0.056) |
Ataxia | 20/192 (9%) | 8/52 (13%) | 12/140 (8%) | 0.295 (0.379) |